Cargando…
HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro
Autores principales: | Bashir, Tahir, Kumar, CS, Reddy, KVR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080394/ http://dx.doi.org/10.1186/1471-2334-14-S3-E30 |
Ejemplares similares
-
HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor
por: Bashir, Tahir, et al.
Publicado: (2015) -
In silico analysis of drug resistance in wild type and mutant HIV-1 subtype d protease
por: Munusami, Punnagai, et al.
Publicado: (2014) -
Docking studies of flavonoid derivatives as potent HIV-1 integrase inhibitors
por: Premjanu, N, et al.
Publicado: (2014) -
Alphalinolenic acid, a potent inhibitor of fatty acid synthase antimycobacterial agent
por: Jainu, Mallika, et al.
Publicado: (2014) -
M. tuberculosis Peptide based Point-of care test for TB
por: Gonzalez, Jesus M, et al.
Publicado: (2014)